Mazzariello Gina 4
4 · Amylyx Pharmaceuticals, Inc. · Filed May 16, 2024
Insider Transaction Report
Form 4
Mazzariello Gina
Chief Legal Officer
Transactions
- Sale
Common Stock
2024-05-15$1.88/sh−10,455$19,654→ 151,477 total
Footnotes (2)
- [F1]The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2023.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.82 to $1.92. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.